
    
      This is a randomized, parallel, double-blind, placebo-controlled study designed to evaluate
      the efficacy and safety of flexibly dosed lurasidone (20 - 80 mg/day) for 6 weeks compared
      with placebo in children and adolescent subjects with depression associated with Bipolar I
      Disorder (bipolar depression).
    
  